$114 Million is the total value of University of Massachusetts Foundation, Inc.'s 5 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IVV | Buy | ISHARES TRcore s&p500 etf | $37,860,000 | +0.6% | 87,878 | +0.4% | 33.24% | +2.7% |
| IEMG | ISHARES INCcore msci emkt | $35,036,000 | -7.8% | 567,297 | 0.0% | 30.76% | -5.9% | |
| VTI | Buy | VANGUARD INDEX FDStotal stk mkt | $20,434,000 | -0.0% | 92,021 | +0.3% | 17.94% | +2.1% |
| IEFA | ISHARES TRcore msci eafe | $20,059,000 | -0.8% | 270,153 | 0.0% | 17.61% | +1.3% | |
| CLOV | New | CLOVER HEALTH INVESTMENTS CO | $518,000 | – | 70,049 | +100.0% | 0.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 16 | Q3 2023 | 52.3% |
| ISHARES INC | 16 | Q3 2023 | 48.5% |
| ISHARES TR | 16 | Q3 2023 | 43.2% |
| ISHARES TR | 10 | Q3 2023 | 35.1% |
| ISHARES TR | 4 | Q3 2020 | 14.7% |
| CLOVER HEALTH INVESTMENTS CO | 4 | Q2 2022 | 0.5% |
| ISHARES TR | 1 | Q1 2020 | 19.4% |
| ISHARES TR | 1 | Q1 2020 | 9.4% |
| PALANTIR TECHNOLOGIES INC | 1 | Q1 2021 | 0.5% |
View University of Massachusetts Foundation, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-31 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-10 |
| 13F-HR/A | 2023-02-13 |
| 13F-HR | 2023-01-24 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View University of Massachusetts Foundation, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.